Furthermore, we found that momelotinib significantly inhibited the growth of HCC cells (Figure 2) and inhibit the phosphorylation of Jak2 and STAT3 and reduce the expression of p-Jak2, which verified the importance of momelotinib in targeting Jak2 and reducing tumorigenesis in HCC. Here, STAT3 is linked to hepatocellular carcinoma.